Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas

scientific article published on July 1983

Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19830701)52:1<51::AID-CNCR2820520111>3.0.CO;2-#
P698PubMed publication ID6850545

P50authorSteven RosenbergQ2347448
P2093author name stringBarr L
Wesley R
Bonow RO
D'Angelo T
Dresdale A
Palmeri ST
Mathison D
P2860cites workRisk factors for doxorubicin-induced congestive heart failureQ28328220
Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac CatheterizationQ28331667
Adriamycin. A new anticancer drug with significant clinical activityQ34699440
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcardiomyopathyQ847583
P304page(s)51-60
P577publication date1983-07-01
P1433published inCancerQ326041
P1476titleProspective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas
P478volume52